Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 15 to 19, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Approves Both Pfizer, Moderna Boosters for All Adults
FRIDAY, Nov. 19, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Friday granted emergency use of both the Pfizer and Moderna COVID-19 booster shots for all adults, clearing the way to additional vaccine protection for tens of millions of Americans.
Read Full Text
New Review Claims First COVID-19 Patient Was Wuhan Market Vendor
FRIDAY, Nov. 19, 2021 (HealthDay News) — The first known person with COVID-19 was a vendor in a large seafood market in Wuhan, China, claims an American scientist whose findings challenge the World Health Organization conclusion that the first patient was an accountant who lived miles from the market.
Read Full Text
ICU Bed Occupancy During COVID-19 Linked to Increase in Excess Deaths
FRIDAY, Nov. 19, 2021 (HealthDay News) — Stress to the health care system, as measured by intensive care unit bed occupancy, is associated with increases in excess deaths two, four, and six weeks later, according to research published in the Nov. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Read Full Text
Access to Care Disrupted for Young Adults With Diabetes in COVID-19
FRIDAY, Nov. 19, 2021 (HealthDay News) — Young adults with diabetes are most likely to report having missed medical care during the COVID-19 pandemic and have lower intention of receiving COVID-19 vaccination, according to research published in the Nov. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Read Full Text
Concerns Raised About COVID-19 Chronic Olfactory Dysfunction
FRIDAY, Nov. 19, 2021 (HealthDay News) — Chronic olfactory dysfunction as a symptom of long-term COVID-19 is emerging as a growing public health concern among U.S. individuals, according to a research letter published online Nov. 18 in JAMA Otolaryngology-Head & Neck Surgery.
Read Full Text
Patients Hospitalized With COVID-19 Less Likely to Be Vaccinated
FRIDAY, Nov. 19, 2021 (HealthDay News) — Patients with COVID-19 hospitalization and disease progression to death or mechanical ventilation are significantly less likely to be vaccinated with an mRNA COVID-19 vaccine, according to a study published online Nov. 4 in the Journal of the American Medical Association.
Read Full Text
Nearly 10 Percent of Younger Children Have Gotten First COVID-19 Vaccine Dose
THURSDAY, Nov. 18, 2021 (HealthDay News) — Almost one in 10 eligible U.S. children ages 5 to 11 years have received a first shot of the Pfizer COVID-19 vaccine since it was approved for that age group two weeks ago, the White House said Wednesday.
Read Full Text
Moderna Asks FDA to Approve Its Booster Shot for All Adults
THURSDAY, Nov. 18, 2021 (HealthDay News) — Moderna asked the U.S. Food and Drug Administration on Wednesday to allow emergency use of the company’s COVID-19 vaccine booster for all adults aged 18 years and older.
Read Full Text
Positive SARS-CoV-2 Test Result Linked to Psychiatric Morbidity
THURSDAY, Nov. 18, 2021 (HealthDay News) — Having a positive severe acute respiratory syndrome coronavirus 2 test result seems to be associated with an increased risk for psychiatric morbidity, fatigue, and sleep problems, according to a study published online Nov. 16 in JAMA Network Open.
Read Full Text
Fewer Deaths Reported With Enrollment in COVID-19 Remote Monitoring
THURSDAY, Nov. 18, 2021 (HealthDay News) — Enrollment in an automated remote monitoring service for adults with COVID-19 at home can help reduce mortality, according to a study published online Nov. 16 in the Annals of Internal Medicine.
Read Full Text
White House to Spend Billions to Boost COVID-19 Vaccine Supply
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The Biden administration plans to invest billions to partner with industry to expand the nation’s ability to produce COVID-19 vaccines, ensure domestic supply, and help poor nations in their vaccination efforts.
Read Full Text
FDA Could Approve Pfizer Booster Shots for All Adults This Week
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — The U.S. Food and Drug Administration is poised to approve the Pfizer COVID-19 booster shots for all American adults as early as Thursday. That would make tens of millions more Americans eligible for the booster doses, sources familiar with the plan told The New York Times.
Read Full Text
Prior Bariatric Surgery May Protect Against Severe COVID-19 Outcomes
WEDNESDAY, Nov. 17, 2021 (HealthDay News) — Bariatric surgery may protect against severe COVID-19 infection and death for patients with morbid obesity, according to a study published in the November issue of Surgery for Obesity and Related Diseases.
Read Full Text
Two Doses of 10 μg BNT162b2 Safe, Efficacious in 5- to 11-Year-Olds
TUESDAY, Nov. 16, 2021 (HealthDay News) — A two-dose regimen of 10 μg of BNT162b2 COVID-19 vaccine administered 21 days apart is safe and efficacious in children aged 5 to 11 years, according to a study published online Nov. 9 in the New England Journal of Medicine.
Read Full Text
Pfizer Asks FDA for Emergency Approval of Its COVID-19 Antiviral Pill
TUESDAY, Nov. 16, 2021 (HealthDay News) — Pfizer announced Tuesday that it has asked the U.S. Food and Drug Administration to approve the emergency use of its new antiviral pill in people at high risk for severe COVID-19.
Read Full Text
Pfizer COVID-19 Pill to Be Made, Sold Cheaply in 95 Poor Countries
TUESDAY, Nov. 16, 2021 (HealthDay News) — Pfizer Inc. announced Tuesday that it has reached an agreement for its promising COVID-19 antiviral pill to be made and sold cheaply in 95 developing nations.
Read Full Text
ACR: Lupus Patients Can Have Low Immune Response to COVID-19 Vaccines
MONDAY, Nov. 15, 2021 (HealthDay News) — Nearly one-third of systemic lupus erythematosus patients have a low response to the COVID-19 vaccine, according to a study presented at the annual meeting of the American College of Rheumatology, held virtually from Nov. 3 to 9.
Read Full Text
SSRIs Linked to Reduced Relative Risk for Mortality in COVID-19
MONDAY, Nov. 15, 2021 (HealthDay News) — For patients with COVID-19, selective serotonin reuptake inhibitors are associated with a reduced relative risk for mortality, according to a study published online Nov. 15 in JAMA Network Open.
Read Full Text
Prior SARS-CoV-2 Infection Ups Protection for Vaccinated
MONDAY, Nov. 15, 2021 (HealthDay News) — For individuals vaccinated with mRNA COVID-19 vaccines, prior severe acute respiratory syndrome coronavirus 2 infection is associated with a lower risk for breakthrough infection, according to a study published online Nov. 1 in the Journal of the American Medical Association.
Read Full Text
Federal Court Backs Stay on COVID-19 Vaccine Mandate for Large Businesses
MONDAY, Nov. 15, 2021 (HealthDay News) — A stay on the Biden administration’s COVID-19 vaccine mandate for large businesses has been upheld by a federal court.
Read Full Text
Copyright © 2021 HealthDay. All rights reserved.
